Literature DB >> 18320236

Diabetes and chronic kidney disease: lessons from the Pima Indians.

Kevin V Lemley1.   

Abstract

Although diabetic nephropathy is a very rare cause of kidney failure during childhood, the underlying events leading to progressive kidney injury begin during childhood in many patients with type 1 diabetes mellitus (T1DM) and in increasing numbers of children with type 2 diabetes mellitus (T2DM). The Pima Indians of Arizona represent an exceptionally thoroughly studied population suffering from very high rates of T2DM and diabetic nephropathy (T2DN). This population well illustrates the often inexorable progression from glomerular hyperfiltration to microalbuminuria to overt proteinuria and loss of glomerular filtration rate (GFR), paralleled by the accumulation of mesangial matrix and basement membrane, glomerular hypertrophy, loss of podocytes and eventual glomerular sclerosis and interstitial fibrosis. Structural changes quantitatively account for the loss of GFR in T2DN. The mechanism of albuminuria (and its relationship to GFR loss) is much less clear. There is strong functional and structural evidence for defects in glomerular size-selectivity (shunts) due to podocyte pathology, but only beginning at relatively high levels of proteinuria (albumin/creatinine ratios > 3000 mg/g). Podocyte loss accompanies, and may underlie, the loss of glomeruli to sclerosis. At this point, most evidence in humans suggests detachment of intact podocytes from the glomerular basement membrane, rather than apoptosis, as the predominant mechanism of podocyte loss.

Entities:  

Mesh:

Year:  2008        PMID: 18320236     DOI: 10.1007/s00467-008-0763-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  47 in total

1.  Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group.

Authors:  R G Nelson; P H Bennett; G J Beck; M Tan; W C Knowler; W E Mitch; G H Hirschman; B D Myers
Journal:  N Engl J Med       Date:  1996-11-28       Impact factor: 91.245

2.  The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience.

Authors:  Georgia Pambianco; Tina Costacou; Demetrius Ellis; Dorothy J Becker; Ronald Klein; Trevor J Orchard
Journal:  Diabetes       Date:  2006-05       Impact factor: 9.461

3.  Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria.

Authors:  T W Meyer; P H Bennett; R G Nelson
Journal:  Diabetologia       Date:  1999-11       Impact factor: 10.122

Review 4.  Understanding the nature of renal disease progression.

Authors:  G Remuzzi; P Ruggenenti; A Benigni
Journal:  Kidney Int       Date:  1997-01       Impact factor: 10.612

5.  Podocyte loss and progressive glomerular injury in type II diabetes.

Authors:  M E Pagtalunan; P L Miller; S Jumping-Eagle; R G Nelson; B D Myers; H G Rennke; N S Coplon; L Sun; T W Meyer
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

6.  Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease.

Authors:  Kathryn Elizabeth White; Rudolf William Bilous
Journal:  J Am Soc Nephrol       Date:  2000-09       Impact factor: 10.121

7.  Similar risks of nephropathy in patients with type I or type II diabetes mellitus.

Authors:  C Hasslacher; E Ritz; P Wahl; C Michael
Journal:  Nephrol Dial Transplant       Date:  1989       Impact factor: 5.992

8.  Structural-functional relationships in diabetic nephropathy.

Authors:  S M Mauer; M W Steffes; E N Ellis; D E Sutherland; D M Brown; F C Goetz
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

9.  Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schönlein-Henoch purpura nephritis.

Authors:  Masanori Hara; Toshio Yanagihara; Itaru Kihara
Journal:  Clin J Am Soc Nephrol       Date:  2007-01-31       Impact factor: 8.237

10.  Segregation analysis of diabetic nephropathy in Pima Indians.

Authors:  G Imperatore; W C Knowler; D J Pettitt; S Kobes; P H Bennett; R L Hanson
Journal:  Diabetes       Date:  2000-06       Impact factor: 9.461

View more
  11 in total

Review 1.  Sodium-glucose transport: role in diabetes mellitus and potential clinical implications.

Authors:  Volker Vallon; Kumar Sharma
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-09       Impact factor: 2.894

2.  Estimating individual glomerular volume in the human kidney: clinical perspectives.

Authors:  Victor G Puelles; Monika A Zimanyi; Terence Samuel; Michael D Hughson; Rebecca N Douglas-Denton; John F Bertram; James A Armitage
Journal:  Nephrol Dial Transplant       Date:  2011-10-09       Impact factor: 5.992

3.  Reproducibility of the NEPTUNE descriptor-based scoring system on whole-slide images and histologic and ultrastructural digital images.

Authors:  Laura Barisoni; Jonathan P Troost; Cynthia Nast; Serena Bagnasco; Carmen Avila-Casado; Jeffrey Hodgin; Matthew Palmer; Avi Rosenberg; Adil Gasim; Chrysta Liensziewski; Lino Merlino; Hui-Ping Chien; Anthony Chang; Shane M Meehan; Joseph Gaut; Peter Song; Lawrence Holzman; Debbie Gibson; Matthias Kretzler; Brenda W Gillespie; Stephen M Hewitt
Journal:  Mod Pathol       Date:  2016-04-22       Impact factor: 7.842

Review 4.  Temporal profile of diabetic nephropathy pathologic changes.

Authors:  Cecilia Ponchiardi; Michael Mauer; Behzad Najafian
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

Review 5.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

6.  Left ventricular hypertrophy and geometry in type 2 diabetes patients with chronic kidney disease. An echocardiographic study.

Authors:  M P Bayauli; F B Lepira; P K Kayembe; J R M'buyamba-Kabangu
Journal:  Cardiovasc J Afr       Date:  2012-03       Impact factor: 1.167

7.  Silencing of Histone Deacetylase 9 Expression in Podocytes Attenuates Kidney Injury in Diabetic Nephropathy.

Authors:  Feng Liu; Ming Zong; Xiaofei Wen; Xuezhu Li; Jun Wang; Yi Wang; Wei Jiang; Xiaojun Li; Zhongliang Guo; Hualin Qi
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

Review 8.  Toll-like receptor 2 and type 2 diabetes.

Authors:  Zahra Sepehri; Zohre Kiani; Ali Akbar Nasiri; Farhad Kohan
Journal:  Cell Mol Biol Lett       Date:  2016-07-28       Impact factor: 5.787

9.  Digital pathology imaging as a novel platform for standardization and globalization of quantitative nephropathology.

Authors:  Laura Barisoni; Charlotte Gimpel; Renate Kain; Arvydas Laurinavicius; Gloria Bueno; Caihong Zeng; Zhihong Liu; Franz Schaefer; Matthias Kretzler; Lawrence B Holzman; Stephen M Hewitt
Journal:  Clin Kidney J       Date:  2017-02-18

10.  Incidence of end-stage renal disease in the Turkish-Cypriot population of Northern Cyprus: a population based study.

Authors:  Thomas M F Connor; D Deren Oygar; Daniel P Gale; Retha Steenkamp; Dorothea Nitsch; Guy H Neild; Patrick H Maxwell
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.